G protein coupled receptor structure and activation

Biochimica et Biophysica Acta - Biomembranes

Volumn 1768, Issue 4, 2007, Pages 794-807

  Kobilka, Brian K ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

7TM; Conformational change; Efficacy; GPCR; Structure

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; G PROTEIN COUPLED RECEPTOR; MEMBRANE RECEPTOR; RHODOPSIN;

CONFORMATIONAL TRANSITION; HUMAN; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ANIMALS; HUMANS; PROTEIN CONFORMATION; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, G-PROTEIN-COUPLED; RHODOPSIN;

EID: 33947356279     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2006.10.021     Document Type: Review

References (103)

1. Ballesteros J.A., and Weinstein H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein coupled receptors. Methods Neurosci. 25 (1995) 366-428
2. Lefkowitz R.J., and Shenoy S.K. Transduction of receptor signals by beta-arrestins. Science 308 5721 (2005) 512-517
3. Luttrell L.M., and Lefkowitz R.J. The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J. Cell. Sci. 115 Pt. 3 (2002) 455-465
4. Azzi M., Charest P.G., Angers S., Rousseau G., Kohout T., Bouvier M., and Pineyro G. Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Proc. Natl. Acad. Sci. U. S. A. 100 20 (2003) 11406-11411
5. Fredriksson R., Lagerstrom M.C., Lundin L.G., and Schioth H.B. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol. Pharmacol. 63 6 (2003) 1256-1272
6. Howard A.D., McAllister G., Feighner S.D., Liu Q., Nargund R.P., Van der Ploeg L.H., and Patchett A.A. Orphan G-protein-coupled receptors and natural ligand discovery. Trends Pharmacol. Sci. 22 3 (2001) 132-140
7. Ji T.H., Grossmann M., and Ji I. G protein-coupled receptors. I. Diversity of receptor-ligand interactions. J. Biol. Chem. 273 28 (1998) 17299-17302
8. Pin J.P., Galvez T., and Prezeau L. Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors. Pharmacol. Ther. 98 3 (2003) 325-354
9. Knoflach F., Mutel V., Jolidon S., Kew J.N., Malherbe P., Vieira E., Wichmann J., and Kemp J.A. Positive allosteric modulators of metabotropic glutamate 1 receptor: characterization, mechanism of action, and binding site. Proc. Natl. Acad. Sci. U. S. A. 98 23 (2001) 13402-13407
10. Carroll F.Y., Stolle A., Beart P.M., Voerste A., Brabet I., Mauler F., Joly C., Antonicek H., Bockaert J., Muller T., Pin J.P., and Prezeau L. BAY36-7620: a potent non-competitive mGlu1 receptor antagonist with inverse agonist activity. Mol. Pharmacol. 59 5 (2001) 965-973
11. Pagano A., Ruegg D., Litschig S., Stoehr N., Stierlin C., Heinrich M., Floersheim P., Prezeau L., Carroll F., Pin J.P., Cambria A., Vranesic I., Flor P.J., Gasparini F., and Kuhn R. The non-competitive antagonists 2-methyl-6-(phenylethynyl)pyridine and 7-hydroxyiminocyclopropan[b]chromen-1a-carboxylic acid ethyl ester interact with overlapping binding pockets in the transmembrane region of group I metabotropic glutamate receptors. J. Biol. Chem. 275 43 (2000) 33750-33758
12. Litschig S., Gasparini F., Rueegg D., Stoehr N., Flor P.J., Vranesic I., Prezeau L., Pin J.P., Thomsen C., and Kuhn R. CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding. Mol. Pharmacol. 55 3 (1999) 453-461
13. Ray K., Tisdale J., Dodd R.H., Dauban P., Ruat M., and Northup J.K. Calindol, a positive allosteric modulator of the human Ca(2+) receptor, activates an extracellular ligand-binding domain-deleted rhodopsin-like seven-transmembrane structure in the absence of Ca(2+). J. Biol. Chem. 280 44 (2005) 37013-37020
14. Ray K., and Northup J. Evidence for distinct cation and calcimimetic compound (NPS 568) recognition domains in the transmembrane regions of the human Ca2+ receptor. J. Biol. Chem. 277 21 (2002) 18908-18913
15. Krebs A., Edwards P.C., Villa C., Li J., and Schertler G.F. The three-dimensional structure of bovine rhodopsin determined by electron cryomicroscopy. J. Biol. Chem. (2003) 50217-50225
16. Krebs A., Villa C., Edwards P.C., and Schertler G.F. Characterisation of an improved two-dimensional p22121 crystal from bovine rhodopsin. J. Mol. Biol. 282 5 (1998) 991-1003
17. Schertler G.F. Structure of rhodopsin. Eye 12 Pt. 3b (1998) 504-510
18. Unger V.M., Hargrave P.A., Baldwin J.M., and Schertler G.F. Arrangement of rhodopsin transmembrane alpha-helices. Nature 389 6647 (1997) 203-206
19. Schertler G.F., Villa C., and Henderson R. Projection structure of rhodopsin. Nature 362 6422 (1993) 770-772
20. Baldwin J.M., Schertler G.F., and Unger V.M. An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. J. Mol. Biol. 272 1 (1997) 144-164
21. Okada T., Le Trong I., Fox B.A., Behnke C.A., Stenkamp R.E., and Palczewski K. X-Ray diffraction analysis of three-dimensional crystals of bovine rhodopsin obtained from mixed micelles. J. Struct. Biol. 130 1 (2000) 73-80
22. Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., Le Trong I., Teller D.C., Okada T., Stenkamp R.E., Yamamoto M., and Miyano M. Crystal structure of rhodopsin: a G protein-coupled receptor [see comments]. Science 289 5480 (2000) 739-745
23. Okada T., Fujiyoshi Y., Silow M., Navarro J., Landau E.M., and Shichida Y. Functional role of internal water molecules in rhodopsin revealed by X-ray crystallography. Proc. Natl. Acad. Sci. U. S. A. 99 9 (2002) 5982-5987
24. Teller D.C., Okada T., Behnke C.A., Palczewski K., and Stenkamp R.E. Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs). Biochemistry 40 26 (2001) 7761-7772
25. Okada T., Sugihara M., Bondar A.N., Elstner M., Entel P., and Buss V. The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure. J. Mol. Biol. 342 2 (2004) 571-583
26. Li J., Edwards P.C., Burghammer M., Villa C., and Schertler G.F. Structure of bovine rhodopsin in a trigonal crystal form. J. Mol. Biol. 343 5 (2004) 1409-1438
27. Okada T., Takeda K., and Kouyama T. Highly selective separation of rhodopsin from bovine rod outer segment membranes using combination of divalent cation and alkyl(thio)glucoside. Photochem. Photobiol. 67 5 (1998) 495-499
28. Edwards P.C., Li J., Burghammer M., McDowell J.H., Villa C., Hargrave P.A., and Schertler G.F. Crystals of native and modified bovine rhodopsins and their heavy atom derivatives. J. Mol. Biol. 343 5 (2004) 1439-1450
29. Schertler G.F. Structure of rhodopsin and the metarhodopsin I photointermediate. Curr. Opin. Struct. Biol. 15 4 (2005) 408-415
30. Fan Q.R., and Hendrickson W.A. Structure of human follicle-stimulating hormone in complex with its receptor. Nature 433 7023 (2005) 269-277
31. Shi L., and Javitch J.A. The binding site of aminergic G protein-coupled receptors: the transmembrane segments and second extracellular loop. Annu. Rev. Pharmacol. Toxicol. 42 (2002) 437-467
32. Elling C.E., Thirstrup K., Nielsen S.M., Hjorth S.A., and Schwartz T.W. Metal-ion sites as structural and functional probes of helix-helix interactions in 7TM receptors. Ann. N. Y. Acad. Sci. 814 (1997) 142-151
33. Ballesteros J.A., Shi L., and Javitch J.A. Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors. Mol. Pharmacol. 60 1 (2001) 1-19
34. Archer E., Maigret B., Escrieut C., Pradayrol L., and Fourmy D. Rhodopsin crystal: new template yielding realistic models of G-protein-coupled receptors?. Trends Pharmacol. Sci. 24 1 (2003) 36-40
35. Tate C.G., and Grisshammer R. Heterologous expression of G-protein-coupled receptors. Trends Biotechnol. 14 11 (1996) 426-430
36. Massotte D. G protein-coupled receptor overexpression with the baculovirus-insect cell system: a tool for structural and functional studies. Biochim. Biophys. Acta. 1610 1 (2003) 77-89
37. Sarramegna V., Talmont F., Demange P., and Milon A. Heterologous expression of G-protein-coupled receptors: comparison of expression systems fron the standpoint of large-scale production and purification. Cell. Mol. Life Sci. 60 8 (2003) 1529-1546
38. Grisshammer R., Averbeck P., and Sohal A.K. Improved purification of a rat neurotensin receptor expressed in Escherichia coli. Biochem. Soc. Trans. 27 6 (1999) 899-903
39. Weiss H.M., and Grisshammer R. Purification and characterization of the human adenosine A(2a) receptor functionally expressed in Escherichia coli. Eur. J. Biochem. 269 1 (2002) 82-92
40. Baneres J.L., Martin A., Hullot P., Girard J.P., Rossi J.C., and Parello J. Structure-based analysis of GPCR function: conformational adaptation of both agonist and receptor upon leukotriene B4 binding to recombinant BLT1. J. Mol. Biol. 329 4 (2003) 801-814
41. Ostermeier C., and Michel H. Crystallization of membrane proteins. Curr. Opin. Struct. Biol. 7 (1997) 697-701
42. Ghanouni P., Gryczynski Z., Steenhuis J.J., Lee T.W., Farrens D.L., Lakowicz J.R., and Kobilka B.K. Functionally different agonists induce distinct conformations in the G protein coupling domain of the beta 2 adrenergic receptor. J. Biol. Chem. 276 27 (2001) 24433-24436
43. Angers S., Salahpour A., and Bouvier M. Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu. Rev. Pharmacol. Toxicol. 42 (2002) 409-435
44. Devi L.A. Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking. Trends Pharmacol. Sci. 22 10 (2001) 532-537
45. Bulenger S., Marullo S., and Bouvier M. Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. Trends Pharmacol. Sci. 26 3 (2005) 131-137
46. Javitch J.A. The ants go marching two by two: oligomeric structure of G-protein-coupled receptors. Mol. Pharmacol. 66 5 (2004) 1077-1082
47. Pin J.P., Kniazeff J., Goudet C., Bessis A.S., Liu J., Galvez T., Acher F., Rondard P., and Prezeau L. The activation mechanism of class-C G-protein coupled receptors. Biol. Cell 96 5 (2004) 335-342
48. Kunishima N., Shimada Y., Tsuji Y., Sato T., Yamamoto M., Kumasaka T., Nakanishi S., Jingami H., and Morikawa K. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature 407 6807 (2000) 971-977
49. Tsuchiya D., Kunishima N., Kamiya N., Jingami H., and Morikawa K. Structural views of the ligand-binding cores of a metabotropic glutamate receptor complexed with an antagonist and both glutamate and Gd3+. Proc. Natl. Acad. Sci. U. S. A. 99 5 (2002) 2660-2665
50. Liang Y., Fotiadis D., Filipek S., Saperstein D.A., Palczewski K., and Engel A. Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes. J. Biol. Chem. 278 24 (2003) 21655-21662
51. Baneres J.L., and Parello J. Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein. J. Mol. Biol. 329 4 (2003) 815-829
52. Mesnier D., and Baneres J.L. Cooperative conformational changes in a G-protein-coupled receptor dimer, the leukotriene B(4) receptor BLT1. J. Biol. Chem. 279 48 (2004) 49664-49670
53. Sakmar T.P. Structure of rhodopsin and the superfamily of seven-helical receptors: the same and not the same. Curr. Opin. Cell Biol. 14 2 (2002) 189-195
54. Sakmar T.P., Franke R.R., and Khorana H.G. The role of the retinylidene Schiff base counterion in rhodopsin in determining wavelength absorbance and Schiff base pKa. Proc. Natl. Acad. Sci. U. S. A. 88 8 (1991) 3079-3083
55. Ridge K.D., Abdulaev N.G., Sousa M., and Palczewski K. Phototransduction: crystal clear. Trends Biochem. Sci. 28 9 (2003) 479-487
56. Hubbell W.L., Altenbach C., Hubbell C.M., and Khorana H.G. Rhodopsin structure, dynamics, and activation: a perspective from crystallography, site-directed spin labeling, sulfhydryl reactivity, and disulfide cross-linking. Adv. Protein Chem. 63 (2003) 243-290
57. Farrens D.L., Altenbach C., Yang K., Hubbell W.L., and Khorana H.G. Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science 274 5288 (1996) 768-770
58. Dunham T.D., and Farrens D.L. Conformational changes in rhodopsin. Movement of helix f detected by site-specific chemical labeling and fluorescence spectroscopy. J. Biol. Chem. 274 3 (1999) 1683-1690
59. Lin S.W., and Sakmar T.P. Specific tryptophan UV-absorbance changes are probes of the transition of rhodopsin to its active state. Biochemistry 35 34 (1996) 11149-11159
60. Sheikh S.P., Zvyaga T.A., Lichtarge O., Sakmar T.P., and Bourne H.R. Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F. Nature 383 6598 (1996) 347-350
61. Altenbach C., Klein-Seetharaman J., Cai K., Khorana H.G., and Hubbell W.L. Structure and function in rhodopsin: mapping light-dependent changes in distance between residue 316 in helix 8 and residues in the sequence 60-75, covering the cytoplasmic end of helices TM1 and TM2 and their connection loop CL1. Biochemistry 40 51 (2001) 15493-15500
62. Altenbach C., Klein-Seetharaman J., Hwa J., Khorana H.G., and Hubbell W.L. Structural features and light-dependent changes in the sequence 59-75 connecting helices I and II in rhodopsin: a site-directed spin-labeling study. Biochemistry 38 25 (1999) 7945-7949
63. Altenbach C., Cai K., Khorana H.G., and Hubbell W.L. Structural features and light-dependent changes in the sequence 306-322 extending from helix VII to the palmitoylation sites in rhodopsin: a site-directed spin-labeling study. Biochemistry 38 25 (1999) 7931-7937
64. Ruprecht J.J., Mielke T., Vogel R., Villa C., and Schertler G.F. Electron crystallography reveals the structure of metarhodopsin I. EMBO J. 23 18 (2004) 3609-3620
65. Salom D., Le Trong I., Pohl E., Ballesteros J.A., Stenkamp R.E., Palczewski K., and Lodowski D.T. Improvements in G protein-coupled receptor purification yield light stable rhodopsin crystals. J. Struct. Biol. (2006) 497-504
66. Mirzadegan T., Benko G., Filipek S., and Palczewski K. Sequence analyses of G-protein-coupled receptors: similarities to rhodopsin. Biochemistry 42 10 (2003) 2759-2767
67. Cerione R.A., Staniszewski C., Benovic J.L., Lefkowitz R.J., Caron M.G., Gierschik P., Somers R., Spiegel A.M., Codina J., and Birnbaumer L. Specificity of the functional interactions of the b-adrenergic receptor and rhodopsin with guanine nucleotide regulatory proteins reconstituted in phospholipid vesicles. J. Biol. Chem. 260 3 (1985) 1493-1500
68. Gether U., Lin S., Ghanouni P., Ballesteros J.A., Weinstein H., and Kobilka B.K. Agonists induce conformational changes in transmembrane domains III and VI of the beta2 adrenoceptor. EMBO J. 16 22 (1997) 6737-6747
69. Jensen A.D., Guarnieri F., Rasmussen S.G., Asmar F., Ballesteros J.A., and Gether U. Agonist-induced conformational changes at the cytoplasmic side of TM 6 in the {beta}2 adrenergic receptor mapped by site-selective fluorescent labeling. J. Biol. Chem. (2000) 9279-9290 (p. Record as supplied by publisher)
70. Ghanouni P., Steenhuis J.J., Farrens D.L., and Kobilka B.K. Agonist-induced conformational changes in the G-protein-coupling domain of the beta 2 adrenergic receptor. Proc. Natl. Acad. Sci. U. S. A. 98 11 (2001) 5997-6002
71. Yao X., Parnot C., Deupi X., Ratnala V.R., Swaminath G., Farrens D., and Kobilka B. Coupling ligand structure to specific conformational switches in the beta(2)-adrenoceptor. Nat. Chem. Biol. (2006) 417-422
72. Sheikh S.P., Vilardarga J.P., Baranski T.J., Lichtarge O., Iiri T., Meng E.C., Nissenson R.A., and Bourne H.R. Similar structures and shared switch mechanisms of the beta2-adrenoceptor and the parathyroid hormone receptor. Zn(II) bridges between helices III and VI block activation. J. Biol. Chem. 274 24 (1999) 17033-17041
73. Elling C.E., Frimurer T.M., Gerlach L.O., Jorgensen R., Holst B., and Schwartz T.W. Metal ion site engineering indicates a global toggle switch model for seven-transmembrane receptor activation. J. Biol. Chem. 281 25 (2006) 17337-17346
74. Javitch J.A., Fu D., Liapakis G., and Chen J. Constitutive activation of the beta2 adrenergic receptor alters the orientation of its sixth membrane-spanning segment. J. Biol. Chem. 272 30 (1997) 18546-18549
75. Rasmussen S.G., Jensen A.D., Liapakis G., Ghanouni P., Javitch J.A., and Gether U. Mutation of a highly conserved aspartic acid in the beta2 adrenergic receptor: constitutive activation, structural instability, and conformational rearrangement of transmembrane segment 6. Mol. Pharmacol. 56 1 (1999) 175-184
76. Ward S.D., Hamdan F.F., Bloodworth L.M., and Wess J. Conformational Changes That Occur during M3 Muscarinic Acetylcholine Receptor Activation Probed by the Use of an in Situ Disulfide Cross- linking Strategy. J. Biol. Chem. 277 3 (2002) 2247-2257
77. Ward S.D., Hamdan F.F., Bloodworth L.M., Siddiqui N.A., Li J.H., and Wess J. Use of an in situ disulfide cross-linking strategy to study the dynamic properties of the cytoplasmic end of transmembrane domain VI of the M3 muscarinic acetylcholine receptor. Biochemistry 45 3 (2006) 676-685
78. Han S.J., Hamdan F.F., Kim S.K., Jacobson K.A., Bloodworth L.M., Li B., and Wess J. Identification of an agonist-induced conformational change occurring adjacent to the ligand-binding pocket of the M(3) muscarinic acetylcholine receptor. J. Biol. Chem. 280 41 (2005) 34849-34858
79. Farahbakhsh Z.T., Hideg K., and Hubbell W.L. Photoactivated conformational changes in rhodopsin: a time-resolved spin label study. Science 262 5138 (1993) 1416-1419
80. Han M., Lin S.W., Minkova M., Smith S.O., and Sakmar T.P. Functional interaction of transmembrane helices 3 and 6 in rhodopsin. Replacement of phenylalanine 261 by alanine causes reversion of phenotype of a glycine 121 replacement mutant. J. Biol. Chem. 271 50 (1996) 32337-32342
81. Jager S., Palczewski K., and Hofmann K.P. Opsin/all-trans-retinal complex activates transducin by different mechanisms than photolyzed rhodopsin. Biochemistry 35 9 (1996) 2901-2908
82. Kenakin T. Efficacy at G-protein-coupled receptors. Nat. Rev., Drug Discov. 1 2 (2002) 103-110
83. Kenakin T. Ligand-selective receptor conformations revisited: the promise and the problem. Trends Pharmacol. Sci. 24 7 (2003) 346-354
84. Lefkowitz R.J., Cotecchia S., Samama P., and Costa T. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol. Sci. 14 8 (1993) 303-307
85. Leff P. The two-state model of receptor activation [see comments]. Trends Pharmacol. Sci. 16 3 (1995) 89-97
86. Weiss J.M., Morgan P.H., Lutz M.W., and Kenakin T.P. The cubic ternary complex receptor-occupancy model. III. resurrecting efficacy. J. Theor. Biol. 181 4 (1996) 381-397
87. Kenakin T. Inverse, protean, and ligand-selective agonism: matters of receptor conformation. FASEB J. 15 3 (2001) 598-611
88. Swaminath G., Xiang Y., Lee T.W., Steenhuis J., Parnot C., and Kobilka B.K. Sequential Binding of Agonists to the {beta}2 Adrenoceptor: kinetic evidence for intermediate conformational states. J. Biol. Chem. 279 1 (2004) 686-691
89. Swaminath G., Deupi X., Lee T.W., Zhu W., Thian F.S., Kobilka T.S., and Kobilka B. Probing the beta2 Adrenoceptor Binding Site with Catechol Reveals Differences in Binding and Activation by Agonists and Partial Agonists. J. Biol. Chem. 280 23 (2005) 22165-22171
90. O'Dowd B.F., Hnatowich M., Regan J.W., Leader W.M., Caron M.G., and Lefkowitz R.J. Site-directed mutagenesis of the cytoplasmic domains of the human b2-adrenergic receptor. Localization of regions involved in G protein- receptor coupling. J. Biol. Chem. 263 31 (1988) 15985-15992
91. Liggett S.B., Caron M.G., Lefkowitz R.J., and Hnatowich M. Coupling of a mutated form of the human beta 2-adrenergic receptor to Gi and Gs. Requirement for multiple cytoplasmic domains in the coupling process. J. Biol. Chem. 266 8 (1991) 4816-4821
92. Subramaniam S., and Henderson R. Molecular mechanism of vectorial proton translocation by bacteriorhodopsin [see comments]. Nature 406 6796 (2000) 653-657
93. Arnis S., Fahmy K., Hofmann K.P., and Sakmar T.P. A conserved carboxylic acid group mediates light-dependent proton uptake and signaling by rhodopsin. J. Biol. Chem. 269 39 (1994) 23879-23881
94. Hoshi T., Zagotta W.N., and Aldrich R.W. Shaker potassium channel gating. I: transitions near the open state. J. Gen. Physiol. 103 2 (1994) 249-278
95. Vilardaga J.P., Steinmeyer R., Harms G.S., and Lohse M.J. Molecular basis of inverse agonism in a G protein-coupled receptor. Nat. Chem. Biol. 1 1 (2005) 25-28
96. Hoffmann C., Gaietta G., Bunemann M., Adams S.R., Oberdorff-Maass S., Behr B., Vilardaga J.P., Tsien R.Y., Ellisman M.H., and Lohse M.J. A FlAsH-based FRET approach to determine G protein-coupled receptor activation in living cells. Nat. Methods 2 3 (2005) 171-176
97. Shi L., Liapakis G., Xu R., Guarnieri F., Ballesteros J.A., and Javitch J.A. Beta2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch. J. Biol. Chem. 277 43 (2002) 40989-40996
98. Mansoor S.E., McHaourab H.S., and Farrens D.L. Mapping proximity within proteins using fluorescence spectroscopy. A study of T4 lysozyme showing that tryptophan residues quench bimane fluorescence. Biochemistry 41 8 (2002) 2475-2484
99. Parnot C., Miserey-Lenkei S., Bardin S., Corvol P., and Clauser E. Lessons from constitutively active mutants of G protein-coupled receptors. Trends Endocrinol. Metab. 13 8 (2002) 336-343
100. Strader C., Candelore M., Hill W., Sigal I., and Dixon R. Identification of two serine residues involved in agonist activation of the β-adrenergic receptor. J. Biol. Chem. 264 (1989) 13572-13578
101. Wieland K., Zuurmond H.M., Krasel C., Ijzerman A.P., and Lohse M.J. Involvement of Asn-293 in stereospecific agonist recognition and in activation of the beta 2-adrenergic receptor. Proc. Natl. Acad. Sci. U. S. A. 93 17 (1996) 9276-9281
102. Liapakis G., Ballesteros J.A., Papachristou S., Chan W.C., Chen X., and Javitch J.A. The forgotten serine. A critical role for Ser-2035.42 in ligans binding to and activation of the beta 2-adrenergic receptor. J. Biol. Chem. 275 48 (2000) 37779-37788
103. Strader C.D., Candelore M.R., Hill W.S., Dixon R.A., and Sigal I.S. A single amino acid substitution in the beta-adrenergic receptor promotes partial agonist activity from antagonists. J. Biol. Chem. 264 28 (1989) 16470-16477